Uncommon karyotypic abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia

Cancer Genetics and Cytogenetics

Volumn 150, Issue 2, 2004, Pages 159-163

  Suzuki, Keijiro ^a   Sugawara, Takeshi ^a   Kowata, Shugo ^a   Utsugizawa, Taiju ^a   Ito, Shigeki ^a   Murai, Kazunori ^a   Ishida, Yoji ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENOCITABINE; HYDROXYUREA; IMATINIB; MITOXANTRONE; PROTEIN TYROSINE KINASE INHIBITOR; RECOMBINANT ALPHA INTERFERON;

ANAMNESIS; ARTICLE; CASE REPORT; CHROMOSOME 11Q; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 19; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 9; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; KARYOTYPE; MALE; METAPHASE; MOLECULAR PROBE; PANCYTOPENIA; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; SOUTHERN BLOTTING;

ADULT; ANTIGENS, CD; BLAST CRISIS; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 19; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID, CHRONIC; MALE; TRANSLOCATION, GENETIC;

EID: 1842610783     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.09.005     Document Type: Article

References (26)

1. Lichtman M.A., Liesveld J.L. Chronic myelogenous leukemia and related disorders. Beutler E., Marshall A.L., Coller B., Kipps T.J., Seligsohn U. Williams hematology. 6th edition :2001;1085-1123 McGraw-Hill, New York.
2. Kantarjian H.M., Keating M.J., Talpatz M., Walters R.S., Smith T.L., Cork A., McCredie K.B., Freireich E.J. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. Am J Med. 83:1987;445-454.
3. Griesshammer M., Heinze B., Bangerter M., Heimpel H., Fliedner T.M. Karyotype abnormalities and their clinical significance in blast crisis at chronic myeloid leukemia. J Mol Med. 75:1997;836-838.
4. Mitelman F. An international system for human cytogenetic nomenclature. 1995;S. Karger, Basel.
5. Majlis A., Smith T.L., Talpaz M., O'Brien S., Rios M.B., Kantarjian H.M. Significance of cytogenetic clonal evolution in chronic myelogenous leukemia. J Clin Oncol. 14:1996;196-203.
6. Cuneo A., Barrieri D., Ferraresi P., Castoldi G.L. A case of chronic myelogenous leukemia with 11q- in blast crisis with monoblastic differentiation. Nou Rev Fr Hematol. 27:1985;389-391.
7. Singh S., Wass J., Vincent P.C., Young G.A., Gunz F.W. Significance of secondary cytogenetic changes in patients with Ph-positive chronic granulocytic leukemia in the acute phase. Cancer Genet Cytogenet. 21:1986;209-220.
8. Sessarego M., Frassoni F., Defferrari R., Bacigalupo A., Fugazza G., Mareni C., Bruzzone R., Dejana A., Ajmar F. Karyotype evolution of Ph posistive chronic myelogenous leukemia patients relapsed in advanced phase of the disease after allogenic bone marrow transplantation. Cancer Genet Cytogenet. 57:1991;69-78.
9. Dastugue N., Duchayne E., Huguet F., Demur C., Plaisancie H., Calvas P., Bourrouillou G., Pris J. Colombies P. t(9;11)(p22;q23) translocation in blastic phase of chronic myeloid leukemia. Cancer Genet Cytogenet. 63:1992;37-42.
10. Li L., Ritterbach J., Harbott J., Schroyens W., Lohmeyer J., Pralle H., Lampert F. Blastic phase chronic myeloid leukemia with four-break rearrangement: t(11;9)(9;22)(q23;p22q34;q11). Cancer Genet Cytogenet. 68:1993;131-134.
11. Dierlamm J., Stefanova M., Michaux L., Lincke E., Leberecht P., Hossfeld D.K. Unusual clinical course and acquisition of del(1)(q23) in second lymphatic blastic phase of a Ph-positive chronic myeloid leukemia. Cancer Genet Cytogenet. 113:1999;85-89.
12. Nishii K., Usui E., Sakakura M., Miyata E., Ridge S.A., Ford A.M., Masuya M., Chen F., Mitani H., Yamaguchi M., Katayama N., Kita K., Shiku H. Additional t(11;17)(q23;q21) in a patient with Ph-positive mixed lineage antigen-expressing leukemia. Cancer Genet Cytogenet. 126:2001;8-12.
13. Rubnitz J.E., Behm F.G., Downing J.R. 11q23 rearrangements in acute leukemias. Leukemia. 10:1996;74-82.
14. Tkachuk D.C., Kohler S., Cleary M.L. Involvement of a homolog of Drosophilia trihorax by 11q23 chromosomal translocations in acute leukemias. Cell. 71:1992;691-700.
15. Djabali M., Selleri L., Parry P., Bower M., Young B.D., Evans G.A. A trithorax-like gene is interrupted by chromosome 11q23 translocation in acute leukemias. Nat Genet. 2:1992;113-118.
16. Ziemin-van der Poel S., McCabe N.R., Gill H.J., Espinosa R., Patel Y., Harden A., Rubinelli P., Smith S.D., Le Beau M.M., Rowley J.D., Diaz M.O. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA. 89:1992;10735-10739.
17. Thirman M.J., Gill H.J., Burnett R.C., Mbangkollo D., McCabe N.R., Kobayashi H., Ziemin-van der Poel S., Kaneko Y., Morgan R., Sandberg A.A., Chaganti R.S.K., Larson R.A., Lebeau M.M., Diaz M.O., Rowley J.D. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med. 329:1993;909-914.
18. Kobayashi H., Espinosa R., Thirman M.J., Gill H.J., Fernald A.A., Diaz M.O., Le Beau M.M., Rowley J.D. Heterogeneity of breakpoints of 11q23 rearrangements in hematologic malignacies identified with fluorescence in situ hybridization. Blood. 82:1993;547-551.
19. Cherif D., Bernard O., Paulien S., James M.R., Le Paslier D., Berger R. Hunting 11q23 deletions with fluorescence in situ hybridization (FISH). Leukemia. 8:1994;578-586.
20. Cherif D., Romana S., Der-Sarkissian H., Jones C., Berger R. Chromosomal painting in acute monocytic leukemia. Genes Chromosomes Cancer. 6:1993;107-112.
21. Kobayashi H., Espinosa R., Thirman M.J., Fernald A.A., Shannon K., Diaz M.O., Le Beau M.M., Rowley J.D. Do terminal deletions of 11q23 exist? Identification of undetected translation with fluorescence in situ hybridization. Genes Chromosomes Cancer. 7:1993;204-208.
22. Cimino G., Moir D.T., Canaani O., Williams K., Crist W.M., Katzav S., Cannizzaro L., Lange B., Nowell P.C., Croce C.M., Canaani E. Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(p21;q23), and t(11;19)(q23;p13) chromosome translocations. Cancer Res. 51:1991;6712-6714.
23. Cimino G., Nakamura T., Gu Y., Canaani O., Prasad R., Crist W.M., Carrol A.J., Baer M., Bloomfield C.D., Nowell P.C., Groce C.M., Canaani E. An altered 11-kilobase transcript in leukemic cell lines with the t(4;11)(q21;q23) chromosome translocation. Cancer Res. 52:1992;3811-3813.
24. Ayton P.M., Cleary M.L. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene. 20:2001;5695-5707.
25. Huret J.L., Brizard A., Slater R., Charrin C., Bertheas M.F., Guilhot F., Hählen K., Kroes W., van Leeuwen E., Van der Shoot E., Beishuizen A., Tanzer J., Hagemeijer A. Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients-updated published cases and 16 new observations. Leukemia. 7:1993;152-160.
26. Slany R.K., Lavau C., Cleary M. The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX. Mol Cell Biol. 18:1998;122-129.